Total Payments
$40,936
2023 Payments
$177.44
Companies
25
Transactions
458
Medicare Patients
1,523
Medicare Billing
$115,756
Payment Breakdown by Category
Other$24,429 (59.7%)
Food & Beverage$9,222 (22.5%)
Consulting$5,188 (12.7%)
Travel$2,010 (4.9%)
Education$87.56 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,430 | 15 | 59.7% |
| Food and Beverage | $9,222 | 417 | 22.5% |
| Consulting Fee | $5,188 | 3 | 12.7% |
| Travel and Lodging | $2,010 | 15 | 4.9% |
| Education | $87.56 | 8 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19,991 | 60 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $7,704 | 32 | $0 (2021) |
| Lilly USA, LLC | $4,644 | 109 | $0 (2023) |
| Novo Nordisk Inc | $3,861 | 75 | $0 (2022) |
| Medtronic MiniMed, Inc. | $1,043 | 36 | $0 (2019) |
| Amgen Inc. | $730.97 | 15 | $0 (2021) |
| AbbVie Inc. | $723.14 | 47 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $322.30 | 23 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $302.63 | 11 | $0 (2021) |
| Shire North American Group Inc | $263.22 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $177.44 | 2 | Bayer Healthcare Pharmaceuticals Inc. ($107.60) |
| 2022 | $228.39 | 2 | Lilly USA, LLC ($124.99) |
| 2021 | $1,262 | 64 | Amgen Inc. ($243.55) |
| 2020 | $981.84 | 70 | Lilly USA, LLC ($232.54) |
| 2019 | $2,230 | 89 | Novo Nordisk Inc ($580.80) |
| 2018 | $3,436 | 86 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,961) |
| 2017 | $32,621 | 145 | Boehringer Ingelheim Pharmaceuticals, Inc. ($17,934) |
All Payment Transactions
458 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/03/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $69.84 | General |
| Category: Diabetes | ||||||
| 02/09/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $107.60 | General |
| Category: Cardio-renal | ||||||
| 07/19/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Diabetes | ||||||
| 06/22/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $103.40 | General |
| Category: Diabetes | ||||||
| 12/14/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/30/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.44 | General |
| Category: Diabetes | ||||||
| 11/23/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Diabetes | ||||||
| 11/09/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/09/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $3.77 | General |
| 11/09/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $0.46 | General |
| 10/28/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2021 | Medtronic, Inc. | InPen (Device) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 10/05/2021 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/15/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: IMMUNOLOGY | ||||||
| 09/02/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Cardiology | ||||||
| 09/01/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $7.05 | General |
| Category: IMMUNOLOGY | ||||||
| 08/25/2021 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/20/2021 | Amgen Inc. | — | Education | In-kind items and services | $13.89 | General |
| 08/17/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $3.68 | General |
| 08/05/2021 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $94.47 | General |
| Category: Bone Health | ||||||
| 08/03/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $2.49 | General |
| Category: Diabetes | ||||||
| 07/08/2021 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $7.11 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/29/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: IMMUNOLOGY | ||||||
| 06/24/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 6 | 526 | 757 | $101,875 | $48,872 |
| 2020 | 7 | 997 | 1,515 | $163,557 | $66,884 |
Total Patients
1,523
Total Services
2,272
Medicare Billing
$115,756
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 269 | 449 | $74,085 | $37,253 | 50.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 123 | 128 | $14,336 | $7,258 | 50.6% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 21 | 67 | $5,762 | $1,735 | 30.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 35 | 35 | $2,450 | $1,282 | 52.3% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 19 | 19 | $4,180 | $1,167 | 27.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 59 | 59 | $1,062 | $177.00 | 16.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 454 | 731 | $120,615 | $52,277 | 43.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 126 | 135 | $15,120 | $6,553 | 43.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 20 | 20 | $5,020 | $2,166 | 43.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 12 | 50 | $4,400 | $1,528 | 34.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 340 | 505 | $9,090 | $1,494 | 16.4% |
| 76536 | Ultrasound of head and neck | Office | 2020 | 21 | 22 | $4,840 | $1,461 | 30.2% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 24 | 52 | $4,472 | $1,404 | 31.4% |
About Dr. Jan Hoffman, MD
Dr. Jan Hoffman, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Newton, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659308229.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jan Hoffman, MD has received a total of $40,936 in payments from pharmaceutical and medical device companies, with $177.44 received in 2023. These payments were reported across 458 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($24,430).
As a Medicare-enrolled provider, Hoffman has provided services to 1,523 Medicare beneficiaries, totaling 2,272 services with total Medicare billing of $115,756. Data is available for 2 years (2020–2021), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Newton, KS
- Active Since 06/27/2006
- Last Updated 09/24/2013
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1659308229
Products in Payments
- JARDIANCE (Drug) $23,281
- SOLIQUA (Drug) $7,432
- Victoza (Drug) $2,480
- Minimed 670G System (Device) $1,031
- TRULICITY (Drug) $677.94
- Saxenda (Drug) $527.64
- Ozempic (Drug) $525.87
- INVOKANA (Drug) $441.28
- SYNTHROID (Drug) $345.79
- Prolia (Biological) $330.58
- FARXIGA (Drug) $302.63
- Synthroid (Drug) $263.41
- NATPARA (Drug) $263.22
- HUMULIN (Drug) $238.16
- Vascepa (Drug) $228.08
- UNITHROID (Drug) $210.49
- MOUNJARO (Drug) $194.83
- TOUJEO (Drug) $177.72
- Repatha (Biological) $167.18
- t-slim insulin pump (Device) $134.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.